Iterum TherapeuticsITRMF
13F holders, Q1 2025 (March 31)18holders −2
2new positions
4sold out
1famous investor
$1.23avg. 13F price*
At the end of Q1 2025, 18 institutions reported holding Iterum Therapeutics PLC (ITRMF) in their 13F filings, down 2 from Q4 2024. 2 opened new positions and 4 sold out. The largest holders were New Leaf Venture Partners, L.L.C. ($424K), Apollon Financial, LLC ($308K) and Renaissance Technologies ($296K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Iterum Therapeutics PLC
- CUSIP
- G6333L200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $137K |
| Exits | 4 | $58K |
All 13F filers, Q4 2024 → Q1 2025: 117,338 shares bought and 240,851 shares sold, net −123,513 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| New Leaf Venture Partners, L.L.C. | 0.95% | No change | 345,020 | $424K |
| Apollon Financial, LLC | 0.07% | No change | 250,250 | $308K |
| Renaissance Technologies | 0.00% | Reduce -45.1% | 240,900 | $296K |
| OneDigital Investment Advisors LLC | 0.00% | New | 101,000 | $124K |
| Two Sigma Investments, LP | 0.00% | No change | 25,245 | $31K |
| Sanctuary Advisors, LLC | 0.00% | No change | 20,000 | $25K |
| Lee Financial Co | 0.00% | No change | 16,000 | $20K |
| Geode Capital Management, LLC | 0.00% | No change | 12,370 | $15K |
| Two Sigma Securities, LLC | 0.00% | New | 10,709 | $13K |
| Alpine Global Management, LLC | 0.00% | Reduce -33.3% | 10,000 | $12K |
| UBS Group AG | 0.00% | Add +183.0% | 8,699 | $11K |
| Morgan Stanley | 0.00% | Reduce -44.8% | 6,473 | $8K |
| Medallion Wealth Advisors, LLC | 0.00% | No change | 1,680 | $2K |
| Activest Wealth Management | 0.00% | No change | 133 | $164 |
| Wells Fargo & Company | 0.00% | No change | 85 | $105 |
| SBI Securities Co., Ltd. | 0.00% | Add +28.6% | 18 | $22 |
| NFSG Corp | 0.00% | No change | 15 | $18 |
| HM Payson & Co. | 0.00% | No change | 3 | $4 |
"% of holder's portfolio" is ITRMF's weight in each manager's 13F, not the share of Iterum Therapeutics PLC the manager owns.